Sunshine Heart Investor News
Sunshine Heart's CEO letter to investors reviews 2010: an A$13.2 million financing, C-Pulse trial growth at newly added hospitals, two senior R&D hires, and a website revamp.
Company
Montreal, OS
Every investor coverage indicates participated in a round Royal Victoria Hospital raised.
Companies Royal Victoria Hospital acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Royal Victoria Hospital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sunshine Heart's CEO letter to investors reviews 2010: an A$13.2 million financing, C-Pulse trial growth at newly added hospitals, two senior R&D hires, and a website revamp.
Sunshine Heart's chief executive reports to shareholders on the C-Pulse trial: halfway through its US feasibility study, first two minimally invasive implants completed and new hospitals in Australia, Canada and the US joining.